Year: 2018
Type: book
Abstract: with USDA/ARS, Dr. Tako's research focuses on various aspects of trace mineral deficiencies, emphasizing molecular, physiological and nutritional factors and practices that influence the intestinal micronutrient absorption.With over 100 peer-reviewed publications and presentations, he leads a research team focused on understanding the interactions between dietary factors, physiological and molecular biomarkers, the microbiome, and intestinal functionality.His research accomplishments include the development of the Gallus gallus intra-amniotic administration procedure, and establishing recognized approaches for using animal models within mineral bioavailability and intestinal absorption screening processes.He has also developed a zinc status physiological blood biomarker (red blood cell Linoleic Acid:Dihomo--Linolenic Acid Ratio), and molecular tissue biomarkers to assess the effect of dietary mineral deficiencies on intestinal functionality, and how micronutrients dietary deficiencies alter gut microbiota composition and function.vii Preface to "Dietary Zn and Human Health"The importance of micronutrients in health and nutrition is undisputable and, among them, zinc is an essential element whose significance to health is increasingly recognized and whose deficiency may play an important role in the appearance of diseases.Zinc is one of the most important trace elements in living organisms with three major biological roles, as catalyst, structural, and regulatory ion.Zinc-binding motifs are found in many proteins encoded by the human genome physiologically, and free zinc is mainly regulated at the single-cell level.Zinc has a critical effect in homeostasis, in immune function, in oxidative stress, in apoptosis, and in aging, and significant disorders of major public health interest are associated with zinc deficiency.In many chronic diseases-including atherosclerosis, several malignancies, neurological disorders, autoimmune diseases, aging, age-related degenerative diseases, and Wilson's disease-concurrent zinc deficiency may complicate the clinical features, affect adversely immunological status, increase oxidative stress, and lead to the generation of inflammatory cytokines.In these diseases, oxidative stress and chronic inflammation may play important causative roles.It is therefore important that the status of zinc is assessed in all cases and zinc deficiency is corrected, since the unique properties of zinc may have significant therapeutic benefits in these diseases.Zinc deficiency is a common ailment predicted to affect 17% of the world's population.Deficiency of zinc is a major cause of early childhood morbidity and mortality.Globally, zinc deficiency is widespread, particularly in rural and developing regions where populations consume cereal-based diets and have less opportunities for diet diversification; however, its presence is also detected in prosperous areas where diets are unbalanced, contributing to "hidden hunger".Although whole blood, plasma, and urine zinc decrease in severe zinc deficiency, accurate assessment of zinc status, especially in mild to moderate deficiency, is difficult as studies with these biomarkers are often contradictory and inconsistent.Hence, considering the complexity of zinc metabolism and absorption, the assessment of marginal zinc status is problematic as there is no universally accepted single measure to assess zinc status.As was indicated by the World Health Organization (WHO), the need to develop additional robust indicators of zinc status and to further expand the already known clinical markers, for which limited data of reliability exists, is evident.Functional biomarkers are those indicators which can detect chronic dysfunctions, such as mild-moderate zinc deficiency, that do not initially present with precise organ pathologies.Functional biomarkers may be well-positioned to indicate zinc deficiency, especially because clinical symptoms are usually absent in mild-moderate zinc deficiency.Due to the paucity of sensitive and specific biological indicators of dietary zinc intake and whole-body zinc status, the WHO has urged further development of Zn indicators, especially those in which a marginal deficiency may be detected.Based upon these recommendations, and in terms of evaluating the efficacy of a zinc intervention (supplement and/or biofortified crop), it is incumbent upon researchers to identify biomarkers which may:(1) respond solely to dietary zinc depletion and repletion; (2) respond rapidly so that early intervention, if necessary, may be properly initiated; (3) indicate sensitivity to all levels of zinc deficiency, especially mild-moderate; (4) appropriately respond to zinc deficiency in both non-healthy and healthy subjects; and (5) be relatively inexpensive and uncomplicated to use and interpret, especially in field circumstances.Further, it remains a central priority to elucidate what, if any, confounding variables exist which can affect the validity, or at least interpretation of, the purported biomarker.This issue is evident in many of the commonly used biomarkers in which, ix for example erythrocyte MT, dietary recall plays an integral role in interpreting the biomarker, yet mistakes in recall are common and can affect the determination of zinc status.In the current manuscript collection, we present a selection of recent knowledge related to dietary zinc and human health, this includes research that discusses updates on zinc dietary requirements, zinc metabolism, zinc deficiency and metabolic disease and zinc status biomarkers.
Source: MDPI eBooks
Author: Tako, Elad
Language: English
Topic: Trace Elements in Health
Subfield: Nutrition and Dietetics
Field: Nursing
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4211245135
